Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 574
5
Diseases
20
Unique genes
0.260
Avg. similarity score
Familial isolated hypoparathyroidism
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Familial isolated hypoparathyroidism
Hypoparathyroidism
Hypoparathyroidism, familial isolated, 2
Hyperparathyroidism
Hypoparathyroidism, familial isolated, 1
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Familial isolated hypoparathyroidism | 4 | 4 | 2 |
| Hypoparathyroidism | 3 | 3 | 3 |
| Hypoparathyroidism, familial isolated, 2 | 3 | 3 | 1 |
| Hyperparathyroidism | 2 | 2 | 19 |
| Hypoparathyroidism, familial isolated, 1 | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GCM2 | 4 / 5 | Familial isolated hypoparathyroidism, Hyperparathyroidism, Hypoparathyroidism, Hypoparathyroidism, familial isolated, 2 |
| PTH | 4 / 5 | Familial isolated hypoparathyroidism, Hyperparathyroidism, Hypoparathyroidism, Hypoparathyroidism, familial isolated, 1 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Parathyroid hormone synthesis, secretion and action | KEGG | 6 / 115 | 31.3× | 2.35e-8 | 1.57e-6 ✓ sig. |
| PTK6 Regulates Cell Cycle | Reactome | 2 / 6 | 200× | 3.94e-5 | 9.03e-4 ✓ sig. |
| Endocrine and other factor-regulated calcium reabsorption | KEGG | 3 / 53 | 34.0× | 8.77e-5 | 1.71e-3 ✓ sig. |
| Class B/2 (Secretin family receptors) | Reactome | 2 / 18 | 66.7× | 3.97e-4 | 5.59e-3 ✓ sig. |
| Rheumatoid arthritis | KEGG | 3 / 95 | 19.0× | 4.96e-4 | 6.64e-3 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 3 / 101 | 17.8× | 5.93e-4 | 7.62e-3 ✓ sig. |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | Reactome | 2 / 23 | 52.2× | 6.53e-4 | 8.20e-3 ✓ sig. |
| Post-translational protein phosphorylation | Reactome | 3 / 108 | 16.7× | 7.21e-4 | 8.85e-3 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 3 / 125 | 14.4× | 1.10e-3 | 1.22e-2 ✓ sig. |
| ADORA2B mediated anti-inflammatory cytokines production | Reactome | 3 / 128 | 14.1× | 1.18e-3 | 1.28e-2 ✓ sig. |
| FoxO signaling pathway | KEGG | 3 / 133 | 13.5× | 1.32e-3 | 1.40e-2 ✓ sig. |
| Measles | KEGG | 3 / 139 | 13.0× | 1.50e-3 | 1.54e-2 ✓ sig. |
| African trypanosomiasis | KEGG | 2 / 37 | 32.5× | 1.69e-3 | 1.69e-2 ✓ sig. |
| Transcriptional Regulation by VENTX | Reactome | 2 / 38 | 31.6× | 1.79e-3 | 1.75e-2 ✓ sig. |
| Cushing syndrome | KEGG | 3 / 155 | 11.6× | 2.05e-3 | 1.93e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| intracellular calcium ion homeostasis | GO:0006874 | 5 / 113 | 41.3× | 1.07e-7 | 1.34e-5 ✓ sig. |
| bone resorption | GO:0045453 | 3 / 26 | 108× | 2.68e-6 | 1.92e-4 ✓ sig. |
| negative regulation of cell population proliferation | GO:0008285 | 6 / 444 | 12.6× | 5.08e-6 | 3.21e-4 ✓ sig. |
| adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway | GO:0140582 | 2 / 5 | 374× | 1.09e-5 | 5.80e-4 ✓ sig. |
| calcium ion homeostasis | GO:0055074 | 3 / 42 | 66.7× | 1.17e-5 | 6.15e-4 ✓ sig. |
| skeletal system development | GO:0001501 | 4 / 151 | 24.8× | 1.79e-5 | 8.54e-4 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 8 / 1,208 | 6.2× | 1.86e-5 | 8.75e-4 ✓ sig. |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 / 7 | 267× | 2.28e-5 | 1.02e-3 ✓ sig. |
| response to glucocorticoid | GO:0051384 | 3 / 53 | 52.9× | 2.37e-5 | 1.05e-3 ✓ sig. |
| response to calcium ion | GO:0051592 | 3 / 55 | 51.0× | 2.65e-5 | 1.14e-3 ✓ sig. |
| bone mineralization | GO:0030282 | 3 / 56 | 50.1× | 2.80e-5 | 1.19e-3 ✓ sig. |
| regulation of G1/S transition of mitotic cell cycle | GO:2000045 | 3 / 57 | 49.2× | 2.96e-5 | 1.24e-3 ✓ sig. |
| negative regulation of cyclin-dependent protein serine/threonine kinase activity | GO:0045736 | 2 / 9 | 208× | 3.90e-5 | 1.53e-3 ✓ sig. |
| response to fibroblast growth factor | GO:0071774 | 2 / 11 | 170× | 5.95e-5 | 2.10e-3 ✓ sig. |
| negative regulation of lipid storage | GO:0010888 | 2 / 12 | 156× | 7.14e-5 | 2.40e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Familial isolated hypoparathyroidism | Hypoparathyroidism | 0.500 | 2 | 2.50e-8 | 1.87e-7 ✓ sig. |
| Familial isolated hypoparathyroidism | Hyperparathyroidism | 0.100 | 2 | 1.43e-6 | 8.51e-6 ✓ sig. |
| Familial isolated hypoparathyroidism | Hypoparathyroidism, familial isolated, 1 | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Familial isolated hypoparathyroidism | Hypoparathyroidism, familial isolated, 2 | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Hypoparathyroidism | Hypoparathyroidism, familial isolated, 1 | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Hypoparathyroidism | Hypoparathyroidism, familial isolated, 2 | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Hyperparathyroidism | Hypoparathyroidism, familial isolated, 2 | 0.050 | 1 | 1.23e-3 | 1.81e-3 ✓ sig. |